Sagimet Biosciences (SGMT) Payables: 2023-2024
Historic Payables for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $1.2 million.
- Sagimet Biosciences' Payables fell 32.31% to $1.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.9 million, marking a year-over-year change of. This contributed to the annual value of $186,000 for FY2023, which is N/A change from last year.
- Per Sagimet Biosciences' latest filing, its Payables stood at $1.2 million for Q3 2024, which was down 42.23% from $2.0 million recorded in Q2 2024.
- In the past 5 years, Sagimet Biosciences' Payables ranged from a high of $2.7 million in Q2 2023 and a low of $186,000 during Q4 2023.
- For the 2-year period, Sagimet Biosciences' Payables averaged around $1.4 million, with its median value being $1.4 million (2023).
- Data for Sagimet Biosciences' Payables shows a maximum YoY slumped of 32.31% (in 2024) over the last 5 years.
- Quarterly analysis of 2 years shows Sagimet Biosciences' Payables stood at $186,000 in 2023, then plummeted by 32.31% to $1.2 million in 2024.
- Its Payables was $1.2 million in Q3 2024, compared to $2.0 million in Q2 2024 and $531,000 in Q1 2024.